Sinopharm unit, CanSinoBIO apply in China for COVID-19 vaccines' public use approval
(Reuters) – A unit of China National Pharmaceutical Group (Sinopharm) and CanSino Biologics Inc (CanSinoBIO) have applied for public use
Read more
(Reuters) – A unit of China National Pharmaceutical Group (Sinopharm) and CanSino Biologics Inc (CanSinoBIO) have applied for public use
Read moreA woman who feared her marriage was over after her husband grew increasingly distant was heartbroken to discover the true
Read moreFox News Flash top headlines for February 23 Fox News Flash top headlines are here. Check out what’s clicking on
Read moreNeuroblastoma is a cancer that develops in nerve tissue, most commonly in the glands around the kidneys. The gene MYCN
Read moreThe cocktail of beneficial bacteria passed from mother to infant through breast milk changes significantly over time and could act
Read moreA new compound made from tree resin kills almost 100% of drug-resistant bacteria without harming healthy tissue, laboratory studies suggest.
Read moreWhile some people in the U.S. have already received the COVID-19 vaccine, there’s a lot of confusion about what they
Read moreFaculty of the Icahn School of Medicine at Mount Sinai Health System, in New York City, circulated an internal memo
Read moreCaused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, coronavirus disease 2019 (COVID-19) is speculated to be involved in
Read moreFox News Flash top headlines for February 23 Fox News Flash top headlines are here. Check out what’s clicking on
Read more